Le Coutre, P; Petzer, A; Saussele, S; Lang, F; Karsch, D; Herhaus, P; Sliwa, T; Wolfler, A; Breccia, M; Turkina, A; Boquimpani, C; Chuah, C; Sharf, G; Schuld, P; Hoch, M; Yssel, J; Zhang, Y; Hochhaus, A.
ASC4OPT Trial in Progress: a Phase 3B Open-label Study to optimize Oral Asciminib Therapy for chronic Myeloid Leukemia in chronic Phase after Pretreatment with 2 TKIs
ONCOL RES TREAT. 2022; 45(SUPPL 2): 122-122.
[Poster]
Web of Science